Panacea Biotec (BOM:531349) Accounts Payable & Accrued Expense : ₹1,538 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Panacea Biotec Accounts Payable & Accrued Expense?

Panacea Biotec's quarterly accounts payable & accrued expense declined from Sep. 2023 (₹1,749 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹1,538 Mil).

Panacea Biotec's annual accounts payable & accrued expense declined from Mar. 2022 (₹2,392 Mil) to Mar. 2023 (₹1,773 Mil) and declined from Mar. 2023 (₹1,773 Mil) to Mar. 2024 (₹1,538 Mil).

Panacea Biotec Accounts Payable & Accrued Expense Historical Data

The historical data trend for Panacea Biotec's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacea Biotec Accounts Payable & Accrued Expense Chart

Panacea Biotec Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

2,467.37

2,714.84

2,392.36

1,773.24

1,538.10

Panacea Biotec Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1,773.24	-	1,748.80	-	1,538.10

Panacea Biotec Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Panacea Biotec (BOM:531349) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacea Biotec Ltd (BOM:531349) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

PANACEABIO:India

Address

Mathura Road, B-1 Extn./G-3, Mohan Co-operative Industrial Estate, New Delhi, IND, 110 044

Website

https://www.panaceabiotec.com

Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.

Panacea Biotec (BOM:531349) Headlines

No Headlines